Reduction of gastrointestinal complications in renal graft recipients after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium.

Reinke, P; Budde, K; Hugo, C; Petersen, P; Schnuelle, P; Fricke, L; Scholz, D; Sperschneider, H; Bahner, U; Kramer, S; Fischer, W; Arns, W

Reinke, P; Budde, K; Hugo, C; Petersen, P; Schnuelle, P; Fricke, L; Scholz, D; Sperschneider, H; Bahner, U; Kramer, S; Fischer, W; Arns, W.

Affiliation

Reinke P; Department of Nephrology, University Hospital Charité, Berlin, Germany.

Transplant Proc ; 43(5): 1641-6, 2011 Jun.

Article in En | MEDLINE | ID: mdl-21693250

Subject(s)

Gastrointestinal Tract/physiopathology; Immunosuppressive Agents/adverse effects; Kidney Transplantation; Mycophenolic Acid/analogs & derivatives; Dosage Forms; Humans; Kidney Transplantation/adverse effects; Mycophenolic Acid/adverse effects; Quality of Life

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Kidney Transplantation / Gastrointestinal Tract / Immunosuppressive Agents / Mycophenolic Acid Type of study: Guideline / Prognostic_studies Aspects: Patient_preference Limits: Humans Language: En Journal: Transplant Proc Year: 2011 Document type: Article Affiliation country: Germany

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google